查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1820631

全球基因分型檢測市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Genotyping Assay Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

全球基因分型檢測市場預計將經歷顯著擴張，預計 2025 年至 2033 年的年複合成長率(CAGR) 為 23.01%。根據市場分析，預計到 2033 年底市場規模將達到 2,708.7 億美元，高於 2024 年的 420 億美元。

全球基因分型檢測市場正經歷快速成長，這得益於個人化醫療、藥物基因體學和疾病研究領域日益成長的應用。高通量定序、微陣列技術和基於 CRISPR 的檢測方法的創新正在提升準確性、速度和成本效益。未來的發展將側重於多重分析能力、自動化以及與生物資訊平台的整合，以實現全面的基因組分析。

此外，遺傳疾病和癌症盛行率的上升，加上研究經費的增加，正在推動市場需求。直接面對消費者的基因檢測和伴隨診斷的成長正在拓寬終端用戶群。監管框架和資料隱私考量正在影響檢測的開發和商業化。隨著基因組學的進步，基因分型檢測市場將持續發展，提供精準、可擴展且臨床相關的解決方案。

目錄

第1章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：基因分型檢測 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務進行市場吸引力分析
    • 按技術分析市場吸引力
    • 市場吸引力分析：按應用
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第5章：全球基因分型檢測市場分析：依產品與服務

  • 按產品和服務概覽
  • 按產品和服務進行歷史和預測資料分析
  • 試劑和試劑盒
  • 基因分型服務
  • 儀器
  • 生物資訊學

第6章：全球基因分型檢測市場分析：依技術

  • 依技術概覽
  • 按技術進行歷史和預測數據分析
  • 聚合酶連鎖反應
  • 微陣列
  • 定序
  • 毛細管電泳
  • 基質輔助雷射解吸電離飛行時間質譜
  • 其他（等位基因特異性寡核苷酸（ASO）探針、螢光原位雜合技術（FISH）等）

第7章：全球基因分型檢測市場分析：依應用

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 藥物基因組學
  • 診斷與個人化醫療
  • 農業生物技術
  • 動物遺傳學
  • 其他（產前檢測、人體法醫、微生物基因體學研究、水產養殖育種研究等）

第 8 章：全球基因分型檢測市場分析：按最終用戶

  • 最終用戶概覽
  • 最終用戶的歷史和預測數據分析
  • 製藥和生物製藥公司
  • 診斷與研究實驗室
  • 學術機構
  • 其他（動物和水產遺傳學公司等）

第9章：全球基因分型檢測市場分析：按地區

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 10 章：基因分型偵測公司的競爭格局

  • 基因分型檢測市場競爭
  • 夥伴關係/合作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Illumina Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • QIAGEN NV
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Agilent Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GE HealthCare Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Standard BioTools Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PerkinElmer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Eurofins Scientific SE
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Rad Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Pacific Biosciences Of California Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GENEWIZ Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Integrated DNA Technologies Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

Product Code: VMR112114273

Global Genotyping Assay Market is anticipated to experience remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 23.01% from 2025 to 2033. According to the market analysis, the market size is forecasted to reach USD 270.87 Billion by the end of 2033, up from USD 42 Billion in 2024.

The global genotyping assay market is experiencing rapid growth driven by increasing applications in personalized medicine, pharmacogenomics, and disease research. Innovations in high-throughput sequencing, microarray technologies, and CRISPR-based assays are enhancing accuracy, speed, and cost-effectiveness. Future developments will focus on multiplexing capabilities, automation, and integration with bioinformatics platforms for comprehensive genomic analysis.

Additionally, rising prevalence of genetic disorders and cancer, coupled with expanding research funding, is propelling market demand. The growth of direct-to-consumer genetic testing and companion diagnostics is broadening end-user segments. Regulatory frameworks and data privacy considerations are shaping assay development and commercialization. As genomics advances, the genotyping assay market will continue to evolve, delivering precise, scalable, and clinically relevant solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Genotyping Assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Reagents & Kits
  • Genotyping Services
  • Instruments
  • Bioinformatics

By Technology

  • PCR
  • Microarrays
  • Sequencing
  • Capillary Electrophoresis
  • MALDI-TOF
  • Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)

By Application

  • Pharmacogenomics
  • Diagnostic & Personalized Medicine
  • Agricultural Biotechnology
  • Animal Genetics
  • Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)

By End-user

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostic & Research Laboratories
  • Academic Institutes
  • Others (Animal and Aquagenetics Companies, etc.)
  • List of Companies Profiled in the report
  • Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Agilent Technologies Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Standard BioTools Inc., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., Pacific Biosciences of California Inc., Genewiz Inc., Integrated DNA Technologies Inc

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENOTYPING ASSAY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1. Overview By Product & Service
  • 5.2. Historical and Forecast Data Analysis By Product & Service
  • 5.3. Reagents & Kits Historic and Forecast Sales By Regions
  • 5.4. Genotyping Services Historic and Forecast Sales By Regions
  • 5.5. Instruments Historic and Forecast Sales By Regions
  • 5.6. Bioinformatics Historic and Forecast Sales By Regions

6. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. PCR Historic and Forecast Sales By Regions
  • 6.4. Microarrays Historic and Forecast Sales By Regions
  • 6.5. Sequencing Historic and Forecast Sales By Regions
  • 6.6. Capillary Electrophoresis Historic and Forecast Sales By Regions
  • 6.7. MALDI-TOF Historic and Forecast Sales By Regions
  • 6.8. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.) Historic and Forecast Sales By Regions

7. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Pharmacogenomics Historic and Forecast Sales By Regions
  • 7.4. Diagnostic & Personalized Medicine Historic and Forecast Sales By Regions
  • 7.5. Agricultural Biotechnology Historic and Forecast Sales By Regions
  • 7.6. Animal Genetics Historic and Forecast Sales By Regions
  • 7.7. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.) Historic and Forecast Sales By Regions

8. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-user
  • 8.2. Historical and Forecast Data Analysis By End-user
  • 8.3. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.4. Diagnostic & Research Laboratories Historic and Forecast Sales By Regions
  • 8.5. Academic Institutes Historic and Forecast Sales By Regions
  • 8.6. Others (Animal and Aquagenetics Companies, etc.) Historic and Forecast Sales By Regions

9. GLOBAL GENOTYPING ASSAY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE GENOTYPING ASSAY COMPANIES

  • 10.1. Genotyping Assay Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF GENOTYPING ASSAY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Illumina Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Thermo Fisher Scientific Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. QIAGEN N.V.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Agilent Technologies Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Danaher Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. F. Hoffmann-La Roche Ltd
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. GE HealthCare Technologies Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Standard BioTools Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. PerkinElmer Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Eurofins Scientific SE
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Bio-Rad Laboratories Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Pacific Biosciences Of California Inc.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. GENEWIZ Inc.
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Integrated DNA Technologies Inc
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product & Service (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Genotyping Services Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • PCR Market Sales By Geography (USD MN)
  • Microarrays Market Sales By Geography (USD MN)
  • Sequencing Market Sales By Geography (USD MN)
  • Capillary Electrophoresis Market Sales By Geography (USD MN)
  • MALDI-TOF Market Sales By Geography (USD MN)
  • Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Pharmacogenomics Market Sales By Geography (USD MN)
  • Diagnostic & Personalized Medicine Market Sales By Geography (USD MN)
  • Agricultural Biotechnology Market Sales By Geography (USD MN)
  • Animal Genetics Market Sales By Geography (USD MN)
  • Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.) Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Diagnostic & Research Laboratories Market Sales By Geography (USD MN)
  • Academic Institutes Market Sales By Geography (USD MN)
  • Others (Animal and Aquagenetics Companies, etc.) Market Sales By Geography (USD MN)
  • Global Genotyping Assay Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genotyping Assay Report
  • Market Research Process
  • Market Research Methodology
  • Global Genotyping Assay Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product & Service
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Product & Service (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Genotyping Services Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • PCR Market Sales By Geography (USD MN)
  • Microarrays Market Sales By Geography (USD MN)
  • Sequencing Market Sales By Geography (USD MN)
  • Capillary Electrophoresis Market Sales By Geography (USD MN)
  • MALDI-TOF Market Sales By Geography (USD MN)
  • Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Pharmacogenomics Market Sales By Geography (USD MN)
  • Diagnostic & Personalized Medicine Market Sales By Geography (USD MN)
  • Agricultural Biotechnology Market Sales By Geography (USD MN)
  • Animal Genetics Market Sales By Geography (USD MN)
  • Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Diagnostic & Research Laboratories Market Sales By Geography (USD MN)
  • Academic Institutes Market Sales By Geography (USD MN)
  • Others (Animal and Aquagenetics Companies, etc.) Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.